Clinical Trial: First-in-human, Single Ascending Dose Study of CEL383 in Healthy Adult Subjects
Study Status: Completed
Recruit Status: RECRUITING
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of CEL383 When Administered Intravenously to Health
Brief Summary:
This is a first-in-human, randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of CEL383 in healthy volunteers.
Read more